All News

Learn how diet and exercise impact breast cancer risk, while getting authoritative guidelines on plate balance, fiber goals, and complex vs. simple carbs.

CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.

All I can say is thank you Healthwell Foundation for giving our brother life, and for giving our whole family unit life. Because of you, we can keep on keeping on.

Ceralasertib plus Imfinzi failed to improve overall survival versus docetaxel in a phase 3 study of previously treated non-small cell lung cancer.

As kidney cancer survival improves, more patients report cognitive changes affecting memory, fatigue, and overall mental clarity

Christmas is my favorite time of year. Since my child was diagnosed with cancer, however, the only gift I want is one more Christmas with her being here.

Trodelvy elicited fewer side effects that led to dose reduction compared with chemotherapy in previously untreated triple-negative breast cancer.

Jace Yawnick explained why a support system is essential for patients with cancer.

I have been diagnosed with breast cancer for the third time, and I find it interesting how the places where I seek support have changed over time.

Trodelvy led to fewer side effects that required dose reductions or stopping treatment vs chemo among previously untreated triple-negative breast cancer.

At the 2025 SABCS, researchers presented findings with the potential to meaningfully affect breast cancer treatment and patient care.

“Full House” star Dave Coulier, now undergoing treatment for tongue cancer, sat down for an interview with CURE.

Enhertu wins breakthrough therapy designation in some patents with HER2+ early breast cancer who have residual disease following neoadjuvant treatment.

Despite its vital function in many patients’ cancer journeys, palliative care is still the subject of several persistent myths and misconceptions.

From new drug approvals to real-world insights on quality of life, here are the top 10 cancer care stories of 2025 that stood out for their patient impact.

Integrative oncology combines standard treatment with evidence-based complementary therapies to manage symptoms and empower patients.

DESTINY-Breast05 analyses show post neoadjuvant Enhertu improves invasive disease free survival compared with Kadcyla in patients with residual early stage breast cancer.

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or more prior treatments.

Dr. Vikram Gorantla explains to CURE that staying healthy and managing side effects helps patients with brain metastases remain on therapy.

Losing an online friend to cancer reminded me that grief is real even across screens and that survivor guilt and gratitude can coexist in the same moment.

Treatment with Lynozyfic showed early responses and a manageable safety profile in patients with newly diagnosed multiple myeloma.

Stage 3 kidney cancer can be managed with surgery, immunotherapy and targeted therapy; knowing your options helps guide informed decisions.

Get expert insight into stage 3 oral cavity cancer, covering diagnosis, multimodal treatment and essential side effect management.

This patient guide explains triple-positive breast cancer, including treatment options, side effects and more to support informed conversations.

A diagnosis of anal cancer can feel overwhelming, but understanding the disease is the first step toward effective management and recovery.

When I was diagnosed with breast cancer, I accepted there would be things I couldn’t completely control.

All I want for Christmas is to talk to and hear from as many readers and writers about their cancer experiences and their lives as I can.

As he faces cancer for the second time since 2024, actor Dave Coulier is incredibly aware of the power of positive thinking.